Terms: = Thyroid cancer AND ER, estrogen receptor AND Staging
15 results:
1. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
2. Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast cancers and thyroid Disease.
Li J; Liu Y; Jin J; Shi Q; Ji Y; Zhang B; Hu P
Mediators Inflamm; 2023; 2023():3133554. PubMed ID: 37152372
[TBL] [Abstract] [Full Text] [Related]
3. Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with Breast cancer.
Lan A; Chen J; Li C; Jin Y; Wu Y; Dai Y; Jiang L; Li H; Peng Y; Liu S
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674372
[TBL] [Abstract] [Full Text] [Related]
4. Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in Intermediate-Risk Papillary thyroid cancer.
Zhang X; Liu JR; Mu ZZ; Cheng XQ; Lin YS
J Clin Endocrinol Metab; 2023 May; 108(6):1330-1337. PubMed ID: 36567646
[TBL] [Abstract] [Full Text] [Related]
5. Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Feng C; Zhan Y; Shao H; Wang Z; Zhu S
J BUON; 2020; 25(2):688-695. PubMed ID: 32521854
[TBL] [Abstract] [Full Text] [Related]
6. 30mCi radioactive iodine achieving comparative excellent response in intermediate/high-risk nonmetastatic papillary thyroid cancer: a propensity score matching study.
Zhang Y; Wang C; Zhang X; Li H; Li X; Lin Y
Endocrine; 2018 Dec; 62(3):655-662. PubMed ID: 30145748
[TBL] [Abstract] [Full Text] [Related]
7. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
Li D; Song H; Wu T; Xie D; Hu J; Zhao J; Shen Q; Fang L
Mol Cell Biochem; 2018 Jul; 444(1-2):169-178. PubMed ID: 29188531
[TBL] [Abstract] [Full Text] [Related]
8. Changes of breast cancer staging when AJCC prognostic staging manual is used: a retrospective analysis of a Chinese cohort.
Ding J; Wu W; Fang J; Chu Y; Zheng S; Jiang L
Int J Biol Markers; 2018 May; 33(2):168-173. PubMed ID: 28967067
[TBL] [Abstract] [Full Text] [Related]
9. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract] [Full Text] [Related]
10. Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: A pitfall in lung cancer diagnosis.
Ono K; Yokota NR; Yoshioka E; Noguchi A; Washimi K; Kawachi K; Miyagi Y; Kato H; Yokose T
Pathol Res Pract; 2016 Jul; 212(7):654-7. PubMed ID: 27113439
[TBL] [Abstract] [Full Text] [Related]
11. In Patients With Low- to Intermediate-Risk thyroid cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy.
Zhao T; Liang J; Guo Z; Li T; Lin Y
Clin Nucl Med; 2016 Jun; 41(6):454-8. PubMed ID: 26914559
[TBL] [Abstract] [Full Text] [Related]
12. ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation.
Magri F; Capelli V; Gaiti M; Villani L; Zerbini F; La Manna L; Rotondi M; Chiovato L
Endocrine; 2015 Jun; 49(2):429-35. PubMed ID: 25338203
[TBL] [Abstract] [Full Text] [Related]
13. Emerging molecular markers for the prognosis of differentiated thyroid cancer patients.
Baldini E; Sorrenti S; Tuccilli C; Prinzi N; Coccaro C; Catania A; Filippini A; Bononi M; De Antoni E; D'Armiento M; Ulisse S
Int J Surg; 2014; 12 Suppl 1():S52-6. PubMed ID: 24862669
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract] [Full Text] [Related]
15. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract] [Full Text] [Related]